- 10
- 0
- 约2.13万字
- 约 12页
- 2023-09-21 发布于湖北
- 举报
The emerging common
framework of a chronic heart
and kidney disorder
Faiez Zannad, MD, PhD
Professor of Therapeutics and Cardiology,
University of Lorraine Medicine, France
Finerenone is indicated for the treatment of chronic kidney disease (with albuminuria) associated with type 2 diabetes in
adults. For prescribing information please refer to the SmPC of the product applicable in your country.
Date of preparation: August 2023
Approval code: MA-M_FIN-NL-0044-1
Disclosures
Professor Zannad has received the following:
• Steering and DSMB Committee
原创力文档

文档评论(0)